Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ECR Pharmaceuticals (Amrix Product Line)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

North American rights to formulate AMRIX. The drug is used as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute musculoskeletal conditions.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • P.O. Box 71600
  • Richmond, VA 23255
  • United States

ECR Pharmaceuticals (Amrix Product Line) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.

Request full access to PitchBook

ECR Pharmaceuticals (Amrix Product Line) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.

Request full access to PitchBook